MedPath

A clinical trial to study and compare the effects of hyaluronidase, dexamethasone and their combination in patients with oral submucous fibrosis

Phase 4
Completed
Conditions
Health Condition 1: null- Oral submucous fibrosis
Registration Number
CTRI/2014/10/005155
Lead Sponsor
STATE BOARD OF MEDICAL RESEARCH
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
90
Inclusion Criteria

Patients clinically diagnosed and histopathologically confirmed as OSF

Exclusion Criteria

Patients having severe systemic problems or pregnant ladies,

patients having history of drug allergy or hypersensitivity to hyaluronidase, dexamethasone or lignocaine,

a previous history of treatment for OSF or malignancy arising in OSF or patients unwilling for treatment

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath